Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 2
2006 1
2007 3
2008 2
2009 1
2010 4
2011 3
2012 2
2013 5
2014 5
2015 5
2016 2
2017 5
2018 4
2019 5
2020 3
2021 2
2022 4
2023 2
2024 6
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative.
Luque J, Mendes I, Gómez B, Morte B, López de Heredia M, Herreras E, Corrochano V, Bueren J, Gallano P, Artuch R, Fillat C, Pérez-Jurado LA, Montoliu L, Carracedo Á, Millán JM, Webb SM, Palau F; CIBERER Network; Lapunzina P. Luque J, et al. Clin Genet. 2022 May;101(5-6):481-493. doi: 10.1111/cge.14113. Epub 2022 Feb 4. Clin Genet. 2022. PMID: 35060122 Free PMC article. Review.
A step forward in methotrexate pharmacogenetics.
Moya P, Corominas H, Salazar J, Díaz-Torné C. Moya P, et al. Among authors: salazar j. Reumatol Clin. 2017 Sep-Oct;13(5):305. doi: 10.1016/j.reuma.2016.12.002. Epub 2017 Jan 16. Reumatol Clin. 2017. PMID: 28110875 Free article. English, Spanish. No abstract available.
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.
Salazar J, Arranz MJ, Martin-Broto J, Serra M, Palmerini E, Martínez-García J, Juan-Ribelles A, Andion M, Martinez-Trufero J, Gutiérrez G, Echebarria-Barona A, Vaz-Salgado MA, Regueiro A, Alvarez R, Valverde C, Luna P, Blay P, Sebio A. Salazar J, et al. Pharmaceuticals (Basel). 2025 Dec 5;18(12):1855. doi: 10.3390/ph18121855. Pharmaceuticals (Basel). 2025. PMID: 41471344 Free PMC article.
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas.
Virgili AC, Salazar J, Gallardo A, López-Pousa A, Terés R, Bagué S, Orellana R, Fumagalli C, Mangues R, Alba-Castellón L, Unzueta U, Casanova I, Sebio A. Virgili AC, et al. Among authors: salazar j. Diagnostics (Basel). 2024 Jun 6;14(11):1195. doi: 10.3390/diagnostics14111195. Diagnostics (Basel). 2024. PMID: 38893721 Free PMC article.
Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy.
Virgili Manrique AC, Salazar J, Arranz MJ, Bagué S, Orellana R, López-Pousa A, Cerdà P, Gracia I, Majercakova K, Peiró A, Trullols L, Fernández M, Valverde S, Quintana MJ, Bell O, Artigas-Baleri A, Sebio A. Virgili Manrique AC, et al. Among authors: salazar j. J Pers Med. 2022 Apr 11;12(4):618. doi: 10.3390/jpm12040618. J Pers Med. 2022. PMID: 35455734 Free PMC article.
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry.
Salazar J, Garcia-Planella E, Fernández-Clotet A, Esteve M, Gisbert JP, Busquets D, Lucendo A, Márquez L, Guardiola J, Martín-Arranz MD, Iglesias E, Monfort D, Villoria A, Cañete F, Bell O, Ricart E, Zabana Y, Chaparro M, Domènech E, Gordillo J; ENEIDA registry of GETECCU. Salazar J, et al. Br J Clin Pharmacol. 2024 May;90(5):1301-1311. doi: 10.1111/bcp.16017. Epub 2024 Feb 18. Br J Clin Pharmacol. 2024. PMID: 38369687 Free article.
65 results